Plain-English translation of NCT06016075 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Kidney Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing three new MRI scanning techniques—hyperpolarised MRI, sodium MRI, and deuterium metabolic imaging—to help doctors better distinguish between benign (harmless) and malignant (cancerous) kidney masses. The goal is to develop imaging tools that can accurately identify which kidney tumors are dangerous and which are not, so patients can avoid unnecessary surgery or procedures.
Currently, many patients with kidney tumors undergo surgery or biopsies only to discover the tumor was actually benign and didn't need treatment. This trial aims to create better imaging tools that can accurately tell benign from malignant tumors before any invasive procedures, potentially sparing patients from unnecessary medical interventions.
You likely qualify if…
You likely don't qualify if…
You will visit the research center for one or more study appointments where you'll have advanced MRI scans. Depending on which scanning technique is being tested, you may receive an injection of a safe, non-radioactive substance while in the scanner, have a standard MRI with different equipment, or drink a sugar drink before your scan. The whole process is non-invasive and designed to gather information about how your kidney mass looks using these new imaging methods.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United Kingdom